Antibodies to adrenal, gonadal tissues and steroidogenic enzymes

Autoantibodies

Volumn , Issue , 2007, Pages 389-401

  Betterle, Corrado ^a   Zanchetta, Renato ^a   Chen, Shu ^b   Furmaniak, Jadwiga ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b RSR LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67649652458     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044452763-9/50054-8     Document Type: Chapter

References (21)

1. Betterle C, Dal Pra C, Mantero F, Zanchetta R Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocrine Rev 2002, 23:327-364.
2. Betterle C Addison's Disease and Autoimmune Polyglandular Syndromes. Immunoendocrinology in Health and Disease 2004, 491-536. Marcel Dekker Inc Publisher, New York. V. Geenen, G. Chrosus (Eds.).
3. Miguel RN, Chen S, Nikfarjam L, Kominami S, Carpenter B, Dal Pra C, Betterle C, Zanchetta R, Nakamatsu T, Powell M, Hewer R, Blundell TL, Rees Smith B, Furmaniak J Analysis of the intereaction between human steroid 21-hydroxylase and various monoclonal antibodies using comparative structural modelling. Eur J Endocrinol 2005, 153:949-961.
4. Furmaniak J, Sanders J, Rees Smith B Autoantigens in the autoimmune endocrinopathies. Contemporary Endocrinology: Autoimmune Endocrinopathies 1999, 183-216. Human Press Inc, Totowa, NJ. R. Volpe (Ed.).
5. Chen S, Sawicka J, Prentice L, Sanders JF, Tanaka H, Petersen V, Betterle C, Volpato M, Roberts S, Powell M, Rees Smith B, Furmaniak J Analysis of autoantibody epitopes on steroid 21-hydroxylase using a panel of monoclonal antibodies. J Clin Endocrinol Metab 1998, 83:2977-2986.
6. Nikfarjam L, Kominami S, Yamazaki T, Chen S, Hewer R, Dal Pra C, Nakamatsu T, Betterle C, Zanchetta R, Rees Smith B, Furmaniak J Mechanism of inhibition of cytochrome P450 C21 enzyme activity by autoantibodies from patients with Addison's disease. Eur J Endocrinol 2005, 152:95-101.
7. Auchus RJ, Miller WL Molecular modeling of human P450c17 (17_-hydroxylase/17,20-lyase): Insights into reaction mechanisms and effects of mutations. Mol Endocrinol 1999, 13:1169-1182.
8. Peterson P, Krohn KJE Mapping of B cell epitopes on steroid 17-_-hydroxylase, an autoantigen in autoimmune polyglandular syndrome type1. Clin Exp Immunol 1994, 98:104-109.
9. Sivozhelezov V, Nicolini C Homology modeling of cytochrome P450scc and the mutations for optimal amperometric sensor. J Theor Biol 2005, 234:479-485.
10. Liiv I, Teesalu K, Peterson P, Clemente MG, Perheentupa J, Uibo R Epitope mapping of cytochrome P450 cholesterol side-chain cleavage enzyme by sera from patients with autoimmune polyglandular syndrome type 1. Eur J Endocrinol 2002, 146:113-119.
11. Tonacchera M, Ferrarini E, Dimida A, Agretti P, De Marco G, De Servi M, Gianetti E, Chiovato L, Pucci E, Dal Pra C, Betterle C, Aghini-Lombardi F, Vitti P, Pinchera A Gonadotrophin receptor blocking antibodies measured by the use of cell lines stably expressing human gonadotrophin receptors are not detectable in women with 46,XX premature ovarian failure. Clin Endocrinol 2004, 61:376-381.
12. Tanaka H, Perez MS, Powell M, Sandres JF, Sawicka J, Chen S, Prentice L, Asawa T, Betterle C, Volpato M, Rees Smith B, Furmaniak J Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipations assay. J Clin Encocrinol Metab 1997, 82:1440-1446.
13. Betterle C, Dal Pra C, Pedini B, Zanchetta R, Albergoni MP, Chen S, Furmaniak S Rees Smith B. Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome Type 2. J Endocrinol Invest 2004, 27:618-621.
14. Betterle C, Coco G, Zanchetta R Adrenal cortex autoantibodies in subjects with normal adrenal function. Best Prac Res Clin Endocrinol Metab 2005, 19:85-99.
15. Falorni A, Laureti S, De Bellis A, Zanchetta R, Tiberti C, Arnaldi G, Bini V, Beck-Peccoz P, Bizzarro A, Dotta F, Mantero F, Bellastella A, Betterle C Santeusanio F on behalf of the SIE Addison study group. Italian Addison network study: Update of diagnostic criteria for the etiological classification of primary adrenal insufficiency. J Clin Endocrinol Metab 2004, 89:1598-1604.
16. Coco G, Dal Pra C, Presotto F, Albergoni MP, Canova C, Pedini B, Zanchetta R, Chen S, Furmaniak J, Rees Smith B, Mantero F, Betterle C Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006, 91:1637-1645.
17. Hoek A, Schoemaker J, Drexhage HA Premature ovarian failure and ovarian autoimmunity. Endocrine Rev 1997, 18:107-134.
18. Dal Pra C, Chen S, Furmaniak J, Rees Smith B, Pedini B, Moscon A, Zanchetta R, Betterle C Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 2003, 148:565-570.
19. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A, Bellastella A, Santeusanio F, De Bellis A Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002, 78:270-279.
20. Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, Furmaniak J, Rees Smith B, Merino MJ, Nelson LM Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46, XX spontaneous premature ovarian failure. Fertil Steril 2005, 84:958-965.
21. Monnier-Barberino P, Forges T, Faure G, Béné MC Gonadal antibodies interfering with female reproduction. Best Prac Res Clin Endocrinol Metab 2005, 19:135-148.